Profil
Hervé Arditty is currently the Chairman of iXCore SASU.
Previously, he was the Chairman & Chief Executive Officer of EXAIL SAS, Director of Terreïs from 2006 to 2012, and Director of VAXON Biotech SA.
Postes actifs de Hervé Arditty
| Sociétés | Poste | Début |
|---|---|---|
iXCore SASU
iXCore SASU Investment ManagersFinance Acts as an alternative investment manager | Président | 20/04/2011 |
Anciens postes connus de Hervé Arditty
| Sociétés | Poste | Fin |
|---|---|---|
| TERREÏS | Directeur/Membre du Conseil | 01/01/2012 |
EXAIL SAS
EXAIL SAS Aerospace & DefenseElectronic Technology Provides navigation, photonics and maritime autonomy solutions | Directeur Général | - |
VAXON Biotech SA
VAXON Biotech SA Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for the treatment of cancers | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Terreïs
Terreïs Real Estate Investment TrustsFinance Invests in office and retail premises | Finance |
EXAIL SAS
EXAIL SAS Aerospace & DefenseElectronic Technology Provides navigation, photonics and maritime autonomy solutions | Electronic Technology |
VAXON Biotech SA
VAXON Biotech SA Pharmaceuticals: MajorHealth Technology Develops therapeutic vaccines for the treatment of cancers | Health Technology |
iXCore SASU
iXCore SASU Investment ManagersFinance Acts as an alternative investment manager | Finance |
















